【mustache hairs stick straight out】Does Market Volatility Impact Axovant Gene Therapies Ltd.'s (NASDAQ:AXGT) Share Price?
If you're interested in Axovant Gene Themustache hairs stick straight outrapies Ltd. (
NASDAQ:AXGT
), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. First, we have company specific volatility, which is the price gyrations of an individual stock. Holding at least 8 stocks can reduce this kind of risk across a portfolio. The second type is the broader market volatility, which you cannot diversify away, since it arises from macroeconomic factors which directly affects all the stocks on the market.
Some stocks mimic the volatility of the market quite closely, while others demonstrate muted, exagerrated or uncorrelated price movements. Beta is a widely used metric to measure a stock's exposure to market risk (volatility). Before we go on, it's worth noting that Warren Buffett pointed out in his 2014 letter to shareholders that 'volatility is far from synonymous with risk.' Having said that, beta can still be rather useful. The first thing to understand about beta is that the beta of the overall market is one. A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market. In comparison a stock with a beta of over one tends to be move in a similar direction to the market in the long term, but with greater changes in price.
See our latest analysis for Axovant Gene Therapies
What does AXGT's beta value mean to investors?
Looking at the last five years, Axovant Gene Therapies has a beta of 1.30. The fact that this is well above 1 indicates that its share price movements have shown sensitivity to overall market volatility. If this beta value holds true in the future, Axovant Gene Therapies shares are likely to rise more than the market when the market is going up, but fall faster when the market is going down. Many would argue that beta is useful in position sizing, but fundamental metrics such as revenue and earnings are more important overall. You can see Axovant Gene Therapies's revenue and earnings in the image below.
NasdaqGS:AXGT Income Statement, March 9th 2020
Could AXGT's size cause it to be more volatile?
Axovant Gene Therapies is a noticeably small company, with a market capitalisation of US$111m. Most companies this size are not always actively traded. Relatively few investors can influence the price of a smaller company, compared to a large company. This could explain the high beta value, in this case.
Story continues
What this means for you:
Since Axovant Gene Therapies has a reasonably high beta, it's worth considering why it is so heavily influenced by broader market sentiment. For example, it might be a high growth stock or have a lot of operating leverage in its business model. In order to fully understand whether AXGT is a good investment for you, we also need to consider important company-specific fundamentals such as Axovant Gene Therapies’s financial health and performance track record. I urge you to continue your research by taking a look at the following:
Future Outlook
: What are well-informed industry analysts predicting for AXGT’s future growth? Take a look at our
free research report of analyst consensus
for AXGT’s outlook.
Financial Health
: Are AXGT’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our
financial health checks here
.
Other High-Performing Stocks
: Are there other stocks that provide better prospects with proven track records? Explore our
free list of these great stocks here
.
If you spot an error that warrants correction, please contact the editor at
. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.
View comments
-
How Bassett (BSET) Stock Stands Out in a Strong IndustryWere Hedge Funds Right About Chipotle Mexican Grill (CMG)?As Currency Values Deflate, Gold Sees Bright HorizonGuggenheim Energy & Income Fund Announces Tender OfferGBP/USD Price Forecast – British Pound Continues to Struggle at Same LevelIMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the FirmBefore You Buy Youngevity International, Inc. (NASDAQ:YGYI), Consider Its VolatilityPost-Pandemic Retirement Planning Strategy Book Launches on June 1, 2020The Benchmark Company Announces Upcoming Technology One on One Virtual Investor ConferenceTrintech Extends Reporting Capabilities in Its Adra Suite with the Launch of Adra Analytics
下一篇:Can You Imagine How Eagle Nice (International) Holdings's (HKG:2368) Shareholders Feel About The 96% Share Price Increase?
- ·Clarivate Analytics Plc (CCC) Q1 Earnings and Revenues Miss Estimates
- ·Is Now The Time To Look At Buying National Beverage Corp. (NASDAQ:FIZZ)?
- ·Trintech Extends Reporting Capabilities in Its Adra Suite with the Launch of Adra Analytics
- ·Shift Announces Its Intention to Commence an Offer to Exchange Its Publicly Traded Warrants
- ·Bioreactors Market Research Report by Material, by Usage, by Scale, by Control Type, by Distrbution - Global Forecast to 2025 - Cumulative Impact of COVID-19
- ·SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses to Contact the Firm
- ·Dow Jumps Over 5% as Stocks Finally Bounce Back
- ·FIRST FIRM TO INVESTIGATE NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Carnival Corporation & Plc and Encourages Investors with Losses of $100,000 to Contact the Firm
- ·Vishay Precision Group, Inc. to Host Earnings Call
- ·Ra Medical Systems, Inc. to Host Earnings Call
- ·Retail sector companies turn to masks, gloves in coronavirus fight
- ·H2O Innovation Secures 7 New Projects, Totalling $7.6 M and Received Notice of Cancellation for One Project
- ·Does Market Volatility Impact Axovant Gene Therapies Ltd.'s (NASDAQ:AXGT) Share Price?
- ·Is Microsoft Corporation (MSFT) A Good Stock To Buy?
- ·Key Things To Consider Before Buying Canaccord Genuity Group Inc. (TSE:CF) For Its Dividend
- ·Bitcoin Falls 11% In Bearish Trade
- ·What Kind Of Shareholders Own Mitek Systems, Inc. (NASDAQ:MITK)?
- ·JPMorgan Chase approved to process $15 billion in new PPP loans
- ·Dow Jumps Over 5% as Stocks Finally Bounce Back
- ·Is MYR Group (MYRG) a Great Value Stock Right Now?
- ·Will Fastly Continue to Surge Higher?
- ·EUR/USD Bullish Break Kick Starts Reversal to 1.13?
- ·CRON INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of a Filing Deadline in a Securities Class Action Against Cronos Group Inc.
- ·Is Sirius International Insurance (SG) A Good Stock To Buy Now?
- ·Genco Shipping & Trading (GNK) Lags Q3 Earnings and Revenue Estimates
- ·Trust Stamp Prepares to Pursue Direct Public Listing on Euronext Growth Market
- ·Expanse Integrates with ServiceNow
- ·CLNY Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Colony Capital, Inc. and Encourages Investors to Contact the Firm
- ·Pinduoduo’s AI strawberry competition offers glimpse of “one-click planting”
- ·Pennsylvania's Democratic governor calls Trump remarks 'partisan attack'
- ·How Does Prosperity Bancshares's (NYSE:PB) P/E Compare To Its Industry, After The Share Price Drop?
- ·A2Z Technologies Lists on Frankfurt Stock Exchange
- ·SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Becton, Dickinson and Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- ·Donald Trump vows 'major' steps to aid US economy amid coronavirus rise
- ·ROSEN, INVESTOR COUNSEL, Reminds Beyond Meat, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses In Excess of $500K to Contact Firm - BYND
- ·5 Value Stocks In The Energy Sector